SciSparc Ltd.

SPRC chart

SciSparc Ltd. news

• Selling Stockholders Look to Offload 76.81M Shares of SciSparc Ltd (SPRC)

  GuruFocus · Nov 9, 5:25 PM EST

• SPRC: SciSparc corrects floor price in November 3 note and warrant

  Quantisnow · Nov 9, 7:53 AM EST

• A typo in SciSparc (SPRC) note and warrant pricing is corrected to $0.11952.

  Stock Titan · Nov 9, 7:48 AM EST

• SciSparc draws $3M from $10M convertible note facility

  Dealroom · Nov 3, 6:02 PM EST

• A warrant for up to 11,457,269 shares accompanies SciSparc (SPRC) convertible financing.

  Stock Titan · Nov 3, 4:51 PM EST

• NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

  Yahoo Finance · Oct 22, 9:02 AM EDT

• SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

  Yahoo Finance · Oct 22, 8:55 AM EDT

• SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications

  Yahoo Finance · Oct 19, 8:35 AM EDT

• SciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance Technologies

  Yahoo Finance · Oct 15, 7:06 AM EDT

• SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Architecture

  Yahoo Finance · Oct 7, 8:22 AM EDT

• SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations

  Yahoo Finance · Sep 23, 8:35 AM EDT

• SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation for Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies

  Yahoo Finance · Sep 2, 9:16 AM EDT

SciSparc Ltd. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-11-03
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-26
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-23
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-15
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-15
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-07
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-30
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-24
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-02
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-26
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-24
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-18

About SciSparc Ltd.

Ticker

SPRC (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Tel Aviv, Israel

Incorporated in

Israel

Fiscal year end

December 31

SEC CIK

1611746

Former names

SciSparc Ltd./ADR, Therapix Biosciences Ltd.

Frequently asked questions